The Company

ClearCut Medical was established to develop and commercialize its proprietary technology and tools for accurate and effective removal of cancer.

ClearCut's platform technology is based on an innovative new form factor Magnetic Resonance (MRI) that enables real-time accurate and rapid margin assessment of excised tissue in the operating room.

The company's first product, the ClearCoast™ MRI System provides intraoperative margin assessment of surgically removed breast cancer tumors. By providing accurate, real-time and simple margin analysis to the surgeon in the OR, the system is able to significantly improve surgical outcomes and reduce re-excision rates.

To date over 400 patients have participated in international, multi-center clinical trials, which have shown excellent accuracy compared to the gold standard final histopathology and the potential to reduce the re-excision rates in breast conserving surgery by 80%.

Future applications include other surgical excisions of cancerous tumors and biopsies throughout the body.

Known & Trusted

No imaging modality is more familiar with and trusted by cancer physicians than magnetic resonance

Accuracy

450+ patients, three studies in US, Europe and Israel, high accuracy compared to microscopic pathology

Impact

Dramatically reduce the need for repeat cancer surgery will relieve patients, help surgeons and save billions

Team

Hezi Himelfarb

CEO

Hezi Himelfarb

Hezi joined ClearCut as CEO in February 2022, bringing with him more than 30 years of management experience in hi-tech and medical device companies. Hezi's last role was CEO of O2Cure, the first and only company that develops blood oxygenators from long-term operation ECMO up to artificial lung. Before O2Cure, Hezi served as General Manager and Chief Operating Officer in Microbot Medical (Nasdaq: MBOT). Prior to Microbot, Hezi was CEO of IceCure Medical (TASE: ICCQ). Before IceCure, Hezi was the CEO of Remon Medical Technologies (sold to Boston Scientific) after spending 4 years in Medtronic-InStent Israel and 14 years at Scitex Corporation. Hezi holds B.Sc. in electronic engineering and an M.B.A, both from Tel-Aviv University.

Eyal Kolka

Co-Founder and Executive Director

Eyal Kolka

Eyal, a serial entrepreneur, has devoted the last twenty years to building medical device start-up companies. He started his career as a physicist for the Israeli Defense Forces. He then went into investment banking joining Sigma P.C.M. Capital Markets as a partner. In 1999 Eyal joined Erez Golan and together they found TopSpin Medical. Eyal served as CFO and Senior VP of Business Development. TopSpin developed a revolutionary miniaturized MRI catheter for diagnosing coronary plaque composition. The company successfully completed clinical trials in the US and Europe, commercialized the product and went public on the Tel-Aviv Stock Exchange in 2005. In 2008 and 2010 Eyal co-founded two new companies with Erez Golan; Pi-Cardia and Clear-Cut. Eyal holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem and an MBA from the Tel Aviv University.

Erez Golan

Co-Founder

Erez Golan

Erez, a serial entrepreneur, devoted the last twenty years to building medical device start-up companies. Earlier in his career he built a strong technology background while leading inter-disciplinary projects for the Israel Air Force. He then went into medical imaging working on novel tissue characterization algorithms for intravascular ultrasound at Medinol. In 1999 Erez founded TopSpin Medical together with Eyal Kolka, which he then led as CEO for eight years. The company successfully completed clinical trials in the US and Europe and went public on the Tel-Aviv Stock Exchange in 2005. In 2008-2010 Erez co-founded Pi-Cardia and Clear-Cut. Erez holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem.

Dr. Barry Rosen

Chief Medical Officer

Dr. Barry Rosen

Dr. Rosen is a breast surgical oncologist in the northwest suburbs of Chicago, where he has been in practice for over 25 years. Dr. Rosen's administrative positions have included Chief Medical Officer, Advocate Healthcare, and Eton Pharmaceuticals. Dr. Rosen is the former chairman of NQMBC (National Quality Metrics for Breast Centers) and participates on the Patient Safety and Quality Committee for the American Society of Breast Surgeons. He is a partner of Targeted Medical Education (TME), a group of national breast cancer leaders who collaborate with industry to promote physician education and research. Locally, he is the medical director for the Breast Centers at Advocate Good Shepherd Hospital and AMITA/Alexian Brothers Medical Center.

Zachi Peles

V.P R&D and Operations

Zachi Peles

10 years of experience in medical device R&D projects, especially in the diagnostic field. Zachi holds BSc. and MSc. degrees in Biomedical Engineering from TA University. Experienced in experimental R&D activities and system engineering with technical skills in Matlab programming, mechanical design (Solidworks) and hands-on lab work and system integration.

Roy Barak

Chief Technology Officer

Roy Barak

Roy brings over 15 years of experience in hardware development, project management, and innovation within the technology and medical device industries. He has led end-to-end development services for numerous companies, specializing in medical engineering. Roy holds a B.Sc. in Electronics Engineering and an ME in Biomedical Engineering.

Dr. Saul Stokar

Chief Scientist

Dr. Saul Stokar

Saul joined ClearCut after 30 years' experience in medical devices, and specifically in MRI including at Elscint, GE and Aspect Imaging. Saul is the author of numerous scientific articles and patents and holds a PhD in physics from Rockefeller University.

Prof. Moshe Papa

Member of the Scientific Advisory Board

Prof. Moshe Papa

Prof. Papa completed his medical studies at Tel Aviv medical school cum laude and underwent surgical training in 1983 at the Mount Sinai hospital in NY, where he spent 2 years as a surgical staff fellow at the National Cancer Institute NIH. In 1992 he returned to Israel as a staff member at the department of surgical oncology at Sheba medical center Tel Aviv Univ. In 1999 Prof. Papa was appointed as the head of the Surgical Oncology division and founded the 'Meirav' Comprehensive Breast Center at Sheba. He has been involved in many Israeli and international innovative projects, including the company's ClearCoast™ MRI System for margin assessment in breast conserving surgeries.

Keren Mesika

Director QA/RA

Matan Saydoff

Software Manager

Matan Saydoff

Leading and managing Software development in Multidisciplinary products for more than 13 years as part of the R&D team. R&D software developer for more than 18 years. Last working place includes Scodix, IAI and Elbit systems. Practical engineer from Ort College, B.A. Computer Science from The Academic College of Tel Aviv-Yaffo, Israel. MBA from the Open University.

Eden Korbashi

Operations Manager

Eden Korbashi

Over 3 years of expertise in medical device R&D and systems integration. Specializes in cross-functional project coordination and the Design Transfer Process. Experienced in production optimization and implementing innovative solutions. B.Sc. in Medical Engineering, Afeka College of Engineering, Israel.

Michael Roitman

NPI & Operations Engineer

Samantha Natanzon

Clinical Manager

Samantha Natanzon

7 years experience in medical device companies. Specializing in clinical research, and managing clinical trial sites across Israel, Europe, and the UK. BSc. in Biomedical Engineering from Afeka College of Engineering, Israel.

Tsipi Kagan

Controller

Emily Mazig

Office Manager

Board Members

Michael Berman

Chairman

Michael Berman

Michael is an entrepreneur and investor working with a select group of high potential development and early commercial stage companies. He currently serves on the boards of 11 medical companies. From 1995-2000 Mr. Berman was President of Boston Scientific/Scimed. From 1997 to 2000 he was a member of Boston Scientific's Executive Committee. In 2010 Mr. Berman was inducted into the Minnesota Business Hall of Fame. He earned a BS and MBA from Cornell University.

Eyal Kolka

Co-Founder and Executive Director

Eyal Kolka

Eyal, a serial entrepreneur, has devoted the last twenty years to building medical device start-up companies. He started his career as a physicist for the Israeli Defense Forces. In 1999 Eyal joined Erez Golan and together they found TopSpin Medical, which went public on the Tel-Aviv Stock Exchange in 2005. In 2008 and 2010 Eyal co-founded Pi-Cardia and Clear-Cut. Eyal holds a BSc in Physics and Mathematics and an MSc in Physics from the Hebrew University in Jerusalem and an MBA from the Tel Aviv University.

Hezi Himelfarb

CEO

Hezi Himelfarb

Hezi joined ClearCut as CEO in February 2022, bringing with him more than 30 years of management experience in hi-tech and medical device companies. Previously CEO of O2Cure, IceCure Medical, and Remon Medical Technologies (sold to Boston Scientific). Hezi holds B.Sc. in electronic engineering and an M.B.A, both from Tel-Aviv University.

Aurel Schoeller

Observer